Pharmaceuticals, Biotechnology and Life Sciences
— Potential $1 Billion Addressable Market Opportunity in the United StatesBOSTON, Oct. 18, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc.…
SUL-DUR first to achieve statistical non-inferiority in 28-day all-cause mortality in carbapenem-resistant Acinetobacter (CRAB) patientsStatistically significant difference in clinical cure…
FOSTER CITY, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage…
Oral Presentation of Clinical Data for TIL in Combination with Pembrolizumabin Immune-Checkpoint Inhibitor Naïve Patients with Advanced Cancers Poster for…
Co-founded by Crinetics, 5AM Ventures and Frazier Healthcare Partners, the New Company Launches with $30M in Initial Financing Provided by…
Four poster presentations add to the evidence of the beneficial effects of lanifibranor therapy on key components of NASH, following…
Sandusky, OH, Oct. 18, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) earlier today announced the launch of…
PRESS RELEASE AB SCIENCE GRANTED AUTHORIZATION FROM THE FRENCH HEALTH AUTHORITY (ANSM) TO INITIATE A STUDY OF AB8939 IN…
KEY FIGURESRevenueYear-to-date September 30, 2021€817.7 millionAt constant exchange rates and scope1+21.2% including companion animals +24.3% food producing animals +15.0%Growth adjusted…
CAMBRIDGE, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) — Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”), a clinical stage pharmaceutical company…